Find results that contain all of your keywords. Content filter is on. Search will return best illustrations, stock vectors and clipart.
Make it so!
You have chosen to exclude "" from your results.

Choose orientation:
Related commercial searches:

imatinib

cancer

drug

molecule

tyrosine

kinase

inhibitor

 skeletal formula src logo vector template design illustration dasatinib saracatinib dual inhibiting both bcr abl kinases bosutinib chronic myelogenous leukemia cml
of 2 ← →
Order by: relevancy of keywords | publishing date | most downloaded

Bcrabl Cartoons, Illustrations & Vector Stock Images

- 28 images
Imatinib cancer drug molecule. Tyrosine-kinase inhibitor. Skeletal formula.
SRC Logo Vector Template Design Illustration
Dasatinib cancer drug molecule. Skeletal formula.
Dasatinib cancer drug molecule. Skeletal formula.
Saracatinib drug molecule. Dual kinase inhibitor, inhibiting both Src and Bcr-Abl tyrosine kinases. Skeletal formula.
Bosutinib chronic myelogenous leukemia CML drug molecule. Tyrosine kinase inhibitor targeting Bcr-Abl and SRc family kinase..
Ponatinib cancer drug molecule. Tyrosine kinase inhibitor used in treatment of chronic myeloid leukemia CML and acute.
Ponatinib cancer drug molecule. Tyrosine kinase inhibitor used in treatment of chronic myeloid leukemia CML and acute.
Bosutinib chronic myelogenous leukemia (CML) drug molecule. Tyrosine kinase inhibitor targeting Bcr-Abl and SRc family kinase
Ponatinib cancer drug molecule. Tyrosine kinase inhibitor used in treatment of chronic myeloid leukemia (CML) and acute
Imatinib cancer drug molecule. Tyrosine-kinase inhibitor. Skeletal formula.
Bosutinib chronic myelogenous leukemia (CML) drug molecule. Tyrosine kinase inhibitor targeting Bcr-Abl and SRc family kinase
Dasatinib molecule. It is used to treat of myelogenous leukemia, CML, and acute lymphoblastic leukemia, ALL. Skeletal chemical
Saracatinib drug molecule. Dual kinase inhibitor, inhibiting both Src and Bcr-Abl tyrosine kinases. Skeletal formula.
Dasatinib molecule. It is used to treat of myelogenous leukemia, CML, and acute lymphoblastic leukemia, ALL. Molecular model. 3D
Dasatinib molecule. It is used to treat of myelogenous leukemia, CML, and acute lymphoblastic leukemia, ALL. Molecular model. 3D
Dasatinib cancer drug molecule. Atoms are represented as spheres with conventional color coding: hydrogen (white), carbon (grey),
Dasatinib molecule. It is used to treat of myelogenous leukemia, CML, and acute lymphoblastic leukemia, ALL. Structural chemical
Dasatinib molecule. It is used to treat of myelogenous leukemia, CML, and acute lymphoblastic leukemia, ALL. Structural chemical
Ponatinib cancer drug molecule. Tyrosine kinase inhibitor used in treatment of chronic myeloid leukemia CML and acute
Dasatinib cancer drug molecule. Atoms are represented as spheres with conventional color coding: hydrogen (white), carbon (grey),
Dasatinib cancer drug molecule. Atoms are represented as spheres with conventional color coding: hydrogen (white), carbon (grey),
Bosutinib chronic myelogenous leukemia CML drug molecule. Tyrosine kinase inhibitor targeting Bcr-Abl and SRc family kinase..
Bosutinib chronic myelogenous leukemia (CML) drug molecule. Tyrosine kinase inhibitor targeting Bcr-Abl and SRc family kinase
Ponatinib cancer drug molecule. Tyrosine kinase inhibitor used in treatment of chronic myeloid leukemia CML and acute.
Ponatinib cancer drug molecule. Tyrosine kinase inhibitor used in treatment of chronic myeloid leukemia CML and acute.
Bosutinib chronic myelogenous leukemia (CML) drug molecule. Tyrosine kinase inhibitor targeting Bcr-Abl and SRc family kinase
Next Page
←↑↓→
See more images